DAVIDSON KEMPNER CAPITAL MANAGEMENT LP - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is and the CUSIP is 48576UAA4. A total of 14 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$15,264,731
-9.2%
25,000,0000.0%0.24%
-31.2%
Q2 2023$16,812,500
-12.7%
25,000,0000.0%0.35%
+7.6%
Q1 2023$19,256,425
+102072.4%
25,000,0000.0%0.33%
+16250.0%
Q4 2022$18,847
-99.9%
25,000,0000.0%0.00%
-99.5%
Q3 2022$19,953,000
+10.0%
25,000,0000.0%0.37%
+16.6%
Q2 2022$18,139,000
-13.3%
25,000,0000.0%0.31%
+16.7%
Q1 2022$20,932,000
+3.7%
25,000,0000.0%0.27%
-9.4%
Q4 2021$20,188,000
+17.4%
25,000,000
+8.7%
0.30%
+20.7%
Q3 2021$17,194,000
-13.9%
23,000,000
+15.0%
0.25%
+58.7%
Q2 2021$19,960,000
-2.3%
20,000,0000.0%0.16%
-23.6%
Q1 2021$20,429,000
-17.9%
20,000,0000.0%0.20%
-30.5%
Q4 2020$24,888,000
+49.9%
20,000,000
+42.9%
0.29%
+23.7%
Q3 2020$16,600,000
-15.1%
14,000,0000.0%0.24%
-50.0%
Q2 2020$19,551,000
-1.5%
14,000,0000.0%0.47%
-10.9%
Q1 2020$19,853,000
-0.4%
14,000,0000.0%0.53%
+18.0%
Q4 2019$19,941,00014,000,0000.45%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
STEELHEAD PARTNERS LLC 20,000,000$25,176,0001.70%
DeepCurrents Investment Group LLC 22,530,000$28,226,0000.74%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 20,000,000$24,888,0000.29%
FARALLON CAPITAL MANAGEMENT LLC 35,000,000$43,527,0000.26%
AQR Arbitrage LLC 4,100,000$5,164,0000.18%
CSS LLC/IL 3,000,000$3,781,0000.14%
Verition Fund Management LLC 6,579,000$8,286,0000.07%
LAZARD ASSET MANAGEMENT LLC 16,500,000$20,780,0000.03%
Citadel Advisors 43,300,000$54,252,0000.01%
CREDIT SUISSE AG/ 5,017,000$6,243,0000.00%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders